. JQ1 decreases cell viability of both TNBC and ER+ breast cancer cell lines. TNBC (MDA-MB-231, BT549) and ER+ (T47D, MCF7) breast cancer cell lines were treated with the indicated concentrations of JQ1 for 48 hours. Changes in cell viability were assayed by trypan blue exclusion assay. Data are presented as mean (n=3) percentage +/-standard deviation (SD) relative to control.
. VPA reduces cell viability which is further potentiated by JQ1 treatment. (A) MDA-MB-231, BT549, T47D and MCF7 cells were treated with increasing concentrations of VPA for 48 hours and assayed by WST-1 cell viability assay. (B) IC 50 values were calculated by GraphPad Prism software. (C) Cells were treated with JQ1 (1 M) and VPA (8 mM for MDA-MB-231, 9 mM for BT549, 4 mM for T47D, 21.4 mM for MCF7) for 48 hours then assayed by WST-1 cell viability assay. Error bars represent SD from n ≥ 3 independent experiments. Significance (P value) of results in A and C was calculated using a two tailed t test (* P<0.05; ** P<0.01; *** P<0.001). mRNA expression is shown relative to the DMSO treated (vehicle) control. Error bars represent SD from n ≥ 3 independent experiments.
